cerca CERCA
Domenica 28 Febbraio 2021
Aggiornato: 14:15
Temi caldi

bought deal offering of

Willow Biosciences Announces Exercise of Over-Allotment Option and Completion of Previously Announced Bought Deal Offering

VANCOUVER, BC, Feb. 19, 2021 /PRNewswire/ -- Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (TSX: WLLW.WT) (OTCQX: CANSF) is pleased to announce that it has closed its previously announced upsized bought deal offering of 17,424,800 common shares (the "Common Shares") of the Company at a price of $1.65 per Common Share, which includes 2,272,800 Common Shares issued pursuant to the exercise in full of the over-allotment option, for aggregate gross proceeds of approximately $28.75 m...

ora in
Prima pagina
articoli
in Evidenza